We have shown in this first Australian study, and one of few international studies, that compared with noninsulin-treated renal patients with T2DM, those treated with insulin had worse hyperglycaemia, more hypoglycaemia, and experienced a greater burden of diabetes-related complications including foot problems, hospitalisation, and a faster decline in renal function. Here, INS is linked to type 2 diabetes mellitus.